1	T-lymphocytes	t-lymphocyte	_	_	_	_	_	_	_
2	from	from	_	_	_	_	_	_	_
3	individuals	individual	_	_	_	_	_	_	_
4	with	with	_	_	_	_	_	_	_
5	filarial	filarial	_	_	_	_	_	_	_
6	inflammatory	inflammatory	_	_	_	_	_	_	_
7	disease	disease	_	_	_	_	_	_	_
8	have	have	_	_	_	_	_	_	_
9	increased	increase	_	_	_	_	_	_	_
10	transendothelial	transendothelial	_	_	_	_	_	_	_
11	migration	migration	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	vitro	vitro	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	in	in	_	_	_	_	_	_	_
3	vitro	vitro	_	_	_	_	_	_	_
4	transendothelial	transendothelial	_	_	_	_	_	_	_
5	migration	migration	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	circulating	circulate	_	_	_	_	_	_	_
8	filarial	filarial	_	_	_	_	_	_	_
9	antigen-specific	antigen-specific	_	_	_	_	_	_	_
10	T-cells	t-cell	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	examined	examine	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	Wuchereria	Wuchereria	_	_	_	_	_	_	_
15	banerofti	banerofti	_	_	_	_	_	_	_
16	infection	infection	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Circulating	circulate	_	_	_	_	_	_	_
2	T-cells	t-cell	_	_	_	_	_	_	_
3	from	from	_	_	_	_	_	_	_
4	individuals	individual	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	filaria-induced	filaria-induced	_	_	_	_	_	_	_
7	lymphatic	lymphatic	_	_	_	_	_	_	_
8	pathology	pathology	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	LP	LP	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	had	have	_	_	_	_	_	_	_
13	significantly	significantly	_	_	_	_	_	_	_
14	greater	great	_	_	_	_	_	_	_
15	migration	migration	_	_	_	_	_	_	_
16	through	through	_	_	_	_	_	_	_
17	unstimulated	unstimulated	_	_	_	_	_	_	_
18	HUVEC	HUVEC	_	_	_	_	_	_	_
19	monolayers	monolayer	_	_	_	_	_	_	_
20	than	than	_	_	_	_	_	_	_
21	did	do	_	_	_	_	_	_	_
22	T-cells	t-cell	_	_	_	_	_	_	_
23	from	from	_	_	_	_	_	_	_
24	asymptomatic	asymptomatic	_	_	_	_	_	_	_
25	infected	infected	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	MF	mf	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	individuals	individual	_	_	_	_	_	_	_
30	(	(	_	_	_	_	_	_	_
31	P	p	_	_	_	_	_	_	_
32	=	=	_	_	_	_	_	_	_
33	0.04	0.04	_	_	_	_	_	_	_
34	)	)	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	MF	MF	_	_	_	_	_	_	_
6	individuals	individual	_	_	_	_	_	_	_
7	where	where	_	_	_	_	_	_	_
8	no	no	_	_	_	_	_	_	_
9	effect	effect	_	_	_	_	_	_	_
10	was	be	_	_	_	_	_	_	_
11	seen	see	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	transendothelial	transendothelial	_	_	_	_	_	_	_
14	migration	migration	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	48-hr	48-hr	_	_	_	_	_	_	_
17	filarial	filarial	_	_	_	_	_	_	_
18	antigen	antigen	_	_	_	_	_	_	_
19	stimulated	stimulated	_	_	_	_	_	_	_
20	T-cells	T-cell	_	_	_	_	_	_	_
21	from	from	_	_	_	_	_	_	_
22	LP	LP	_	_	_	_	_	_	_
23	individuals	individual	_	_	_	_	_	_	_
24	was	be	_	_	_	_	_	_	_
25	significantly	significantly	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	P	p	_	_	_	_	_	_	_
28	=	=	_	_	_	_	_	_	_
29	0.01	0.01	_	_	_	_	_	_	_
30	)	)	_	_	_	_	_	_	_
31	greater	great	_	_	_	_	_	_	_
32	than	than	_	_	_	_	_	_	_
33	migration	migration	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	48-hr	48-hr	_	_	_	_	_	_	_
36	media-stimulated	media-stimulated	_	_	_	_	_	_	_
37	T-cells	t-cell	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	six	six	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	seven	seven	_	_	_	_	_	_	_
5	patients	patient	_	_	_	_	_	_	_
6	examined	examine	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	inhibition	inhibition	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	VLA-4/VCAM-1	vla-4/vcam-1	_	_	_	_	_	_	_
12	pathway	pathway	_	_	_	_	_	_	_
13	resulted	result	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	greater	great	_	_	_	_	_	_	_
16	than	than	_	_	_	_	_	_	_
17	50	50	_	_	_	_	_	_	_
18	%	%	_	_	_	_	_	_	_
19	inhibition	inhibition	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	transendothelial	transendothelial	_	_	_	_	_	_	_
22	migration	migration	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	T-cells	T-cell	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

